Beta Blockers Cut CV Events by 25% in Post-MI Patients with Mildly Reduced LVEF: Meta-Analysis
Long-term oral β-blocker therapy, including bisoprolol, metoprolol, and carvedilol, reduces the composite endpoint of all-cause death, new myocardial infarction, or heart failure by 25% in patients with MI and mildly…